The United States authorizes the use of “Pfizer” and “Moderna” for children

The US Food and Drug Administration has authorized the emergency use of the "Pfizer" and "Moderna" vaccines for children, paving the way for the start of a campaign to vaccinate children with these two vaccines next week in the United States.

The emergency use of the “Moderna” vaccine, in two doses, was permitted for children aged between six months and five years, and the “Pfizer” vaccine in three doses for children aged between six months and four years.

This age group is the last group that has not yet received the vaccine that protects it from the virus in the United States and several countries.

At the same time, the US Food and Drug Administration approved the "Moderna" vaccine for children aged 6 to 17 years.

"Many parents, caregivers, and clinicians have been waiting for a vaccine for young children, and this procedure will protect babies from 6 months of age," Department President Robert Califf said in a statement today.

"As we've seen for older groups, vaccinations for younger children will protect against the most severe cases of COVID-19, such as hospitalization and mortality," he added.

The Centers for Disease Control and Prevention (CDC) must now also recommend these vaccines before the campaign begins.

Final approval will be given after a meeting of expert members of an advisory committee, to be held on Friday and Saturday.

But the US government indicated that once the FDA’s decision is issued, it can immediately start sending about ten million doses to various parts of the country, before sending millions more in the following weeks.

Follow our latest local and sports news and the latest political and economic developments via Google news